ASX-listed Bod Australia signs deal to produce hemp-based mānuka honey

Sophie Boot
Thu, 18 Jan 2018

By Sophie Boot Jan. 18 (BusinessDesk) - ASX-listed Bod Australia has signed an agreement with mānuka honey producer Manuka Pharma to produce a hemp-based honey product line. Bod, a developer and distributor of cosmetics and natural medicines, is aiming to develop a range of over-the-counter and therapeutic products using cannabis extracts. It says it's building a sustainable, multi-faceted cannabis business through a deal with Swiss manufacturer Linnea Natural Pharma Solutions. The honey agreement will see Manuka Pharma source, develop an...

Not convinced yet?

Subscribe to our Daily News Update free newsletter.

Opinion FREE
Brian Gaynor: a 'titan' of NZ's capital markets
Jenny Ruth | Sat, 21 May 2022

Brian Roche remembers Brian Gaynor as "sorta scary and impressive at the same time – a real 'conscience' of what was right and fair." 

On the Money
On the Money: Brian Gaynor tributes, Damien Grant's slip-up, Marsden Point and more
Pattrick Smellie | Sat, 21 May 2022

OTM this week: Tributes to a legend of the NZ investment world, who forgot to BCC their who's who subscriber list, a slightly bemusing no smoking note at the Budget lockup and more. 

Law & Regulation
Unlawful collection of Companies Office fees fixed under urgency
Ian Llewellyn | Fri, 20 May 2022

The Companies Office's administration of fees may have saved costs, but the problem is it was against the law.

Partner content
What’s driving the ram raids, and what shop owners can do

Scott La Franchie explains the motivations behind the spate of burglaries.

Partner content
Grow your business by taking time to plan

Getting business fundamentals right gives the best chance at beating the unplannable.